Header Logo

Connection

SARA SEXSON TEJTEL to Recurrence

Back to Details
This is a "connection" page, showing publications SARA SEXSON TEJTEL has written about Recurrence.
SARA SEXSON TEJTEL
Connection Strength
0.036
Recurrence
  1. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial. Lancet Child Adolesc Health. 2021 12; 5(12):852-861.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.